Search research articles
Contact Us
Filters
Showing results (71-80 of 90) with videos related to
Page
of 9
Sort By:
Science Advances
|
November 12, 2021
Cancer-associated MSC drive tumor immune exclusion and resistance to immunotherapy, which can be overcome by Hedgehog inhibition
Sandra Cascio, Chelsea Chandler, Linan Zhang, et al.
Science Advances
|
June 1, 2022
Spatial interplay patterns of cancer nuclei and tumor-infiltrating lymphocytes (TILs) predict clinical benefit for immune checkpoint inhibitors
Xiangxue Wang, Cristian Barrera, Kaustav Bera, et al.
JCO Precision Oncology
|
February 9, 2022
Precision Oncology in Solid Tumors: A Longitudinal Tertiary Care Center Experience
Meena Sadaps, Pauline Funchain, Haider Mahdi, et al.
JCO Precision Oncology
|
September 16, 2021
Ceralasertib-Mediated ATR Inhibition Combined With Olaparib in Advanced Cancers Harboring DNA Damage Response and Repair Alterations (Olaparib Combinations)
Haider Mahdi, Navid Hafez, Deborah Doroshow, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 20, 2022
Phase I Trial Combining Chemokine-Targeting with Loco-Regional Chemoimmunotherapy for Recurrent, Platinum-Sensitive Ovarian Cancer Shows Induction of CXCR3 Ligands and Markers of Type 1 Immunity
Brian Orr, Haider Mahdi, Yusi Fang, et al.
Cancer
|
March 11, 2026
Targeted therapy for DNA damage response and homologous recombination repair defects: The Olaparib Combinations trial
Deborah B Doroshow, Geoffrey I Shapiro, Khanh Do, et al.
Gynecologic Oncology Reports
|
October 17, 2022
Clinical factors associated with failed sentinel lymph node mapping in endometrial cancer
Alison A Garrett, Alyssa Wield, Brigid Mumford, et al.
Brachytherapy
|
May 2, 2025
Twice daily template-based interstitial brachytherapy for gynecologic cancers: What is the optimal dose?
Ria Mulherkar, David Grimm, Paniti Sukumvanich, et al.
Journal of Radiosurgery and SBRT
|
April 26, 2021
Stereotactic body radiotherapy for the treatment of oligometastatic gynecological malignancy in the abdomen and pelvis: A single-institution experience
Timothy D Smile, Chandana A Reddy, George Qiao-Guan, et al.
JCI Insight
|
August 16, 2022
Phase I trial of ribociclib with platinum chemotherapy in ovarian cancer
Lan G Coffman, Taylor J Orellana, Tianshi Liu, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 90) with videos related to
Sort By:
Page
of 9
Science Advances
|
November 12, 2021
Cancer-associated MSC drive tumor immune exclusion and resistance to immunotherapy, which can be overcome by Hedgehog inhibition
Sandra Cascio, Chelsea Chandler, Linan Zhang, et al.
Science Advances
|
June 1, 2022
Spatial interplay patterns of cancer nuclei and tumor-infiltrating lymphocytes (TILs) predict clinical benefit for immune checkpoint inhibitors
Xiangxue Wang, Cristian Barrera, Kaustav Bera, et al.
JCO Precision Oncology
|
February 9, 2022
Precision Oncology in Solid Tumors: A Longitudinal Tertiary Care Center Experience
Meena Sadaps, Pauline Funchain, Haider Mahdi, et al.
JCO Precision Oncology
|
September 16, 2021
Ceralasertib-Mediated ATR Inhibition Combined With Olaparib in Advanced Cancers Harboring DNA Damage Response and Repair Alterations (Olaparib Combinations)
Haider Mahdi, Navid Hafez, Deborah Doroshow, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 20, 2022
Phase I Trial Combining Chemokine-Targeting with Loco-Regional Chemoimmunotherapy for Recurrent, Platinum-Sensitive Ovarian Cancer Shows Induction of CXCR3 Ligands and Markers of Type 1 Immunity
Brian Orr, Haider Mahdi, Yusi Fang, et al.
Cancer
|
March 11, 2026
Targeted therapy for DNA damage response and homologous recombination repair defects: The Olaparib Combinations trial
Deborah B Doroshow, Geoffrey I Shapiro, Khanh Do, et al.
Gynecologic Oncology Reports
|
October 17, 2022
Clinical factors associated with failed sentinel lymph node mapping in endometrial cancer
Alison A Garrett, Alyssa Wield, Brigid Mumford, et al.
Brachytherapy
|
May 2, 2025
Twice daily template-based interstitial brachytherapy for gynecologic cancers: What is the optimal dose?
Ria Mulherkar, David Grimm, Paniti Sukumvanich, et al.
Journal of Radiosurgery and SBRT
|
April 26, 2021
Stereotactic body radiotherapy for the treatment of oligometastatic gynecological malignancy in the abdomen and pelvis: A single-institution experience
Timothy D Smile, Chandana A Reddy, George Qiao-Guan, et al.
JCI Insight
|
August 16, 2022
Phase I trial of ribociclib with platinum chemotherapy in ovarian cancer
Lan G Coffman, Taylor J Orellana, Tianshi Liu, et al.
Page
of 9